Presentation THT 2026 Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements Presenter: Tom Heywood March 04, 2026
Presentation THT 2026 VENUS Patch™:A Dual-Site, Noninvasive Venous Congestion Sensor for Early Detection of Heart Failure Decompensation Presenter: Juliana Giorgi March 04, 2026
Presentation THT 2026 Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies Presenter: Thierry Sarda March 04, 2026
Presentation THT 2026 Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure Presenter: Remi Sabatier March 04, 2026
Presentation THT 2026 Time for a Separate Guideline Path for HF Devices? Presenter: Javed Butler March 04, 2026
Presentation THT 2026 Revisiting Surrogate Endpoints in Clinical Trials of HF Devices Presenter: James Januzzi March 04, 2026
Presentation THT 2026 The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies Presenter: Gregg W. Stone March 04, 2026
Presentation THT 2026 Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality? Presenter: John A. Spertus March 04, 2026
Presentation THT 2026 First Reported Real-World Outcomes of the Bodyport Cardiac Scale and Congestion Index in Heart Failure Presenter: Marat Fudim March 04, 2026
Presentation THT 2026 The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved? Presenter: JoAnn Lindenfeld March 04, 2026
Presentation THT 2026 Sustained Passive Physiologic Monitoring Using a Device-Agnostic AI-Enabled Platform: A Pilot Study in Chronic Heart Failure Patients Presenter: Afnan Tariq March 04, 2026
Presentation THT 2026 Interatrial Shunts: Reflections of a Seasoned Practitioner Presenter: John R. Teerlink March 04, 2026
Presentation THT 2026 Experiences With Implant-Free Interatrial Shunting Presenter: James E. Udelson March 04, 2026
Presentation THT 2026 The Effects Of Istaroxime In Patients With Acute Heart Failure (AHF) And Cardiogenic Shock (CS) – Combined Analysis Of 5 Phase 2 Placebo Controlled Clinical Trials Presenter: Beth A. Davison March 04, 2026
Presentation THT 2026 Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness Presenter: Ryan J. Tedford March 04, 2026
Presentation THT 2026 Evaluation of RV Function in Shunt Trials — Does it Matter? Presenter: Joao L. Cavalcante March 04, 2026
Presentation THT 2026 The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial Presenter: Jeffrey Testani March 04, 2026
Presentation THT 2026 Appraising the Risk of Harm in HFpEF and the Likelihood of Benefit in HFrEF Presenter: Sheldon E. Litwin March 04, 2026